No Data
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Materials, Software Stocks Are Best Poised for H1 Outperformance: Goldman Sachs
Eli Lilly's Zepbound Receives FDA Approval For Obesity-Linked Sleep Apnea Drug
Eli Lilly and Co's Zepbound has been approved by the FDA for the treatment of obstructive sleep apnea.
① The FDA in the USA approved Eli Lilly and Co's weight loss medication Zepbound on Friday for the treatment of obstructive sleep apnea (OSA), making it the first drug approved for directly treating this common sleep disorder; ② The active ingredient in Zepbound is Tirzepatide, which was initially used to treat type 2 diabetes, namely Eli Lilly and Co's Mounjaro.
Wall Street Suffers Worst Week in Over a Month After Fed Delivers a Reality Check
![[RRG] Short Term Rotations Putting XLV and XLK Back In Favor](https://sgsnsimg.moomoo.com/sns_client_feed/101760671/20241203/cfc5aaf7620c6702f9e11a58c48f33d8.png/thumb?area=101&is_public=true)
![[RRG] Short Term Rotations Putting XLV and XLK Back In Favor](https://sgsnsimg.moomoo.com/sns_client_feed/101760671/20241203/0060d34c08d5abf7da56d7110f45a41f.png/thumb?area=101&is_public=true)
![[RRG] Short Term Rotations Putting XLV and XLK Back In Favor](https://sgsnsimg.moomoo.com/sns_client_feed/101760671/20241203/5a649cfd4a9614652eef79d2b2d6ab87.png/thumb?area=101&is_public=true)
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
